Benzodiazepines increase the likelihood of both infectious and thrombotic complications

Edward Skicki1, Madison Morgan, Catherine Brown

  • 1From the Trauma and Acute Care Surgery, Penn Medicine Lancaster General Health, Lancaster, Pennsylvania.

Abstract

Insights

Benzodiazepines (BZDs) in trauma patients increase the risk of infectious and thrombotic complications. Infections in these patients further elevate the likelihood of thrombotic events, highlighting a critical link between BZD use and adverse outcomes.

Area of Science:

  • Immunology
  • Trauma Surgery
  • Pharmacology

Background:

  • Benzodiazepines (BZDs) modulate immune responses by inhibiting proinflammatory cytokines, potentially increasing infection risk.
  • Infections are known to elevate the risk of thrombotic complications.
  • The combined impact of BZDs and infection on trauma patient outcomes requires investigation.

Purpose of the Study:

  • To investigate the association between benzodiazepine (BZD) use and the incidence of infectious and thrombotic complications in trauma patients.
  • To determine if infections in BZD-positive trauma patients further increase thrombotic complication rates.

Main Methods:

  • Retrospective analysis of the Pennsylvania Trauma Outcome Study database (2003-2018).
  • Inclusion of trauma patients with positive urine drug screens (UDS) for BZDs.
  • Logistic regression models were used to assess the impact of BZDs on infectious and thrombotic complications, controlling for covariates.

Main Results:

  • Patients with BZDs on admission UDS showed significantly higher rates of both infectious (3.33% vs. 1.76%) and thrombotic (2.84% vs. 1.62%) complications.
  • Multivariate analysis confirmed that BZDs significantly increased the odds of both infectious and thrombotic complications.
  • Trauma patients with BZDs who developed infections had 1.65 times higher odds of experiencing thrombotic complications.

Conclusions:

  • Benzodiazepine (BZD) use in trauma patients is associated with increased odds of infectious and thrombotic complications.
  • Infectious complications in BZD-positive trauma patients further elevate the risk of thrombotic events.

Related Concept Videos

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
748
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
464
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.6K
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
611
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
304
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.2K